Literature DB >> 26976143

Editorial in response to: PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesion formation? : Is there prognostic value in evaluation of 18F-FDG uptake in the pericoronary adipose tissue?

Stephanie L Thorn1, Albert J Sinusas2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26976143     DOI: 10.1007/s12350-016-0458-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  30 in total

1.  Dual energy imaging and intracycle motion correction for CT coronary angiography in patients with intermediate to high likelihood of coronary artery disease.

Authors:  Patricia Carrascosa; Alejandro Deviggiano; Jonathon A Leipsic; Carlos Capunay; Macarena C De Zan; Alejandro Goldsmit; Gaston A Rodriguez-Granillo
Journal:  Clin Imaging       Date:  2015-07-23       Impact factor: 1.605

Review 2.  Quantification of epicardial fat by computed tomography: why, when and how?

Authors:  Mohamed Marwan; Stephan Achenbach
Journal:  J Cardiovasc Comput Tomogr       Date:  2013-01-19

Review 3.  Inflammation modulation and cardiovascular disease prevention.

Authors:  Zuhier Awan; Jacques Genest
Journal:  Eur J Prev Cardiol       Date:  2014-04-07       Impact factor: 7.804

4.  Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG).

Authors:  R J Lederman; R R Raylman; S J Fisher; P V Kison; H San; E G Nabel; R L Wahl
Journal:  Nucl Med Commun       Date:  2001-07       Impact factor: 1.690

Review 5.  The value of imaging in subclinical coronary artery disease.

Authors:  Marco Zimarino; Francesco Prati; Riccardo Marano; Francesca Angeramo; Irene Pescetelli; Laura Gatto; Valeria Marco; Isabella Bruno; Raffaele De Caterina
Journal:  Vascul Pharmacol       Date:  2016-02-04       Impact factor: 5.773

6.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

7.  Association of systemic inflammation with epicardial fat and coronary artery calcification.

Authors:  Sören Gauss; Lutz Klinghammer; Alina Steinhoff; Dorette Raaz-Schrauder; Mohamed Marwan; Stephan Achenbach; Christoph D Garlichs
Journal:  Inflamm Res       Date:  2015-03-13       Impact factor: 4.575

8.  Effect of intracycle motion correction algorithm on image quality and diagnostic performance of computed tomography coronary angiography in patients with suspected coronary artery disease.

Authors:  Patricia Carrascosa; Alejandro Deviggiano; Carlos Capunay; Macarena C De Zan; Alejandro Goldsmit; Gaston A Rodriguez-Granillo
Journal:  Acad Radiol       Date:  2014-10-03       Impact factor: 3.173

9.  Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study.

Authors:  Amir A Mahabadi; Nils Lehmann; Hagen Kälsch; Tim Robens; Marcus Bauer; Iryna Dykun; Thomas Budde; Susanne Moebus; Karl-Heinz Jöckel; Raimund Erbel; Stefan Möhlenkamp
Journal:  JACC Cardiovasc Imaging       Date:  2014-09

10.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

View more
  1 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.